Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b)

Molecular Endocrinology

Volumn 16, Issue 6, 2002, Pages 1394-1406

  Greenhalgh, Christopher J ^a   Bertolino, Patrick ^a   Asa, Sylvia L ^a   Metcalf, Donald ^a   Corbin, Jason E ^b   Adams, Timothy E ^b   Davey, Helen W ^c   Nicola, Nicos A ^d   Hilton, Douglas J ^e   Alexander, Warren S ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d CSIRO   (Australia)

^e RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH HORMONE; SOMATOMEDIN C; STAT5B PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MESSENGER RNA; MILK PROTEIN; PROTEIN; REPRESSOR PROTEIN; SOCS2 PROTEIN, MOUSE; STAT5 PROTEIN; STAT5B PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO DEVELOPMENT; GENE DELETION; GROWTH REGULATION; HORMONAL REGULATION; LIVER CELL; MORPHOGENESIS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOMATIC CELL; ANIMAL; BODY WEIGHT; CELL LINE; DRUG EFFECT; FEMALE; GENETICS; GROWTH; HYPOPHYSIS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; SKIN; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CELL LINE; DNA-BINDING PROTEINS; FEMALE; GENE DELETION; GROWTH; GROWTH HORMONE; HEPATOCYTES; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; MILK PROTEINS; PHOSPHORYLATION; PITUITARY GLAND; PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS;

EID: 85047681536     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.6.0845     Document Type: Article

References (57)

1. A family of cytokine-inducible inhibitors of signalling
2. Structure and function of a new STAT-induced STAT inhibitor
3. A new protein containing an SH2 domain that inhibits JAK kinases
4. Twenty proteins containing a C-terminal SOCS box form five structural classes
5. SOCS: Physiological suppressors of cytokine signaling
6. The suppressors of cytokine signaling (SOCS) proteins. Important feedback inhibitors of cytokine action
7. Negative regulation of cytokine signaling pathways
8. Differential regulation of signaling pathways for insulin and insulin-like growth factor I
9. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
10. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor
11. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat
12. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
13. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone
14. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
15. Cis desensitizes GH induced Stat5 signaling in rat liver cells
16. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
17. SOCS1 is a critical inhibitor of interferon γ, signaling and prevents the potentially fatal neonatal actions of this cytokine
18. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
19. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
20. Stat5a is mandatory for adult mammary gland development and lactogenesis
21. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
22. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
23. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice
24. SOCS3 is essential in the regulation of fetal liver erythropoiesis
25. Gigantism in mice lacking suppressor of cytokine signalling-2
26. Metallothionein-human GH fusion genes stimulate growth of mice
27. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
28. Control of growth by the somatropic axis: Growth hormone and the insulin-like growth factors have related and independent roles
29. Growth hormone and bone
30. Growth hormone stimulates longitudinal bone growth directly
31. Regulation of insulin-like growth factor I gene expression by growth hormone
32. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth
33. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors
34. Signal transduction pathways leading to insulin-induced early gene induction
35. Role of insulin-like growth factors in embryonic and postnatal growth
36. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
37. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
38. Lack of Socs2 expression causes the high growth phenotype in mice
39. Growth hormone and insulin-like growth factor-I measurements in high growth (hg) mice
40. Similarities and differences among prolactin and growth hormone and their receptors
41. Contrasting acute in vivo nuclear actions of growth hormone and prolactin
42. Multiple forms of prolactin receptor messenger ribonucleic acid are specifically expressed and regulated in murine tissues and the mammary cell line HC11
43. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse
44. Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation
45. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
46. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein
47. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription
48. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation
49. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver
50. Insulin induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 skeletal muscle cells is mediated by Stat5*
51. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines
52. Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo
53. Growth hormone and the adipose conversion of 3T3 cells
54. The role of the IGF1 receptor in the regulation of cdc2 mRNA levels in fibroblasts
55. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity
56. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
57. Evidence for growth hormone (GH)autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice